Published in Drug Week, December 16th, 2005
The product is a combination of Toprol-XL (metoprolol succinate extended-release (ER) and the thiazide diuretic, hydrochlorothiazide (HCT).
Toprol-XL is already approved in the United States as a treatment for hypertension administered alone and/or in combination with other agents. Additional approved indications include the long-term treatment of angina pectoris, and the treatment of stable, symptomatic (NYHA Class II or III) heart failure of ischemic, hypertensive, or...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.